Recent Advances in Controlled Release and Targeted Drug Delivery Formulations for Improved Efficacy and Reduced Side Effects
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 March 2027 | Viewed by 1336
Editor
Special Issue Information
Dear Colleagues,
Over the past few decades, significant progress has been achieved in the controlled release and targeted delivery of a wide range of drugs, advances which have greatly improved therapeutic efficacy while reducing adverse effects. Despite these ongoing efforts, important challenges remain in developing new and more effective pharmaceutical dosage forms and in demonstrating their performance.
In this Special Issue, we focus on novel delivery systems that enable effective targeting and site-specific drug release. We welcome original research articles covering the design, manufacturing, characterization, and in vitro and in vivo evaluation of new pharmaceutical formulations, and review articles are also welcome. Your contributions and scientific findings will inspire researchers and professionals in both academia and the pharmaceutical industry. We look forward to receiving your submissions.
Dr. Dongjin Jang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmaceutical formulation
- controlled release
- drug targeting
- improved efficacy
- local drug delivery
- reduced side effect
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
